IP Library Granted Patent US 9,877,731
Granted Patent B2
US 9,877,731 · App. 15/236,135 · Granted Jan 30, 2018

Embolization device constructed from expansile polymer

Inventors: Gregory M. Cruise (Rancho Santa Margarita, CA); Michael Constant (Mission Viejo, CA); Terrance Tran (Westminster, CA); Joseph Gulachenski (Trabuco Canyon, CA)
Assignee: MicroVention, Inc.
A61B17/1219A61B17/1214A61B17/12113A61B17/12145A61B17/12154A61B17/12168A61L31/00A61L31/041A61L31/048A61L31/06A61L31/14A61L31/145A61L31/146A61L2400/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,877,731
App. No.
15/236,135
Granted
Jan 30, 2018
Kind
B2
Abstract

Devices for the occlusion of body cavities, such as the embolization of vascular aneurysms and the like, and methods for making and using such devices. The devices may be comprised of novel expansile materials, novel infrastructure design, or both. The devices provided are very flexible and enable deployment with reduced or no damage to bodily tissues, conduits, cavities, etceteras.

Claims (25)

1. An occlusion device consisting essentially of:

an elongated, solid expansile element, that is flexible in an untreated state, consisting essentially of a poly(ethylene glycol) macromer and a pH sensitive monomer; and

a carrier element comprising a plurality of loops forming a helical shape disposed around the expansile element

wherein the elongated, solid, flexible expansile element is secured to the carrier element in a stretched configuration that is between about 125% and about 600% of its initial length.

2. The occlusion device of claim 1 , wherein the carrier element is between about 0.005 inches and about 0.035 inches in diameter.

3. The occlusion device of claim 1 , wherein the pH sensitive monomer is sodium acrylate.

4. The occlusion device of claim 1 , wherein the plurality of loops are spaced by gaps.

5. The occlusion device of claim 4 , wherein at least one gap is configured to allow the elongated expansile element to expand through the at least one gap.

6. The occlusion device of claim 5 , wherein the at least one gap has a distance of about 0.00025 inches to about 0.2 inches.

7. The occlusion device of claim 6 , wherein the at least one gap has a distance of about 0.00025 inches to about 0.005 inches.

8. The occlusion device of claim 5 , wherein the at least one gap has a distance of about 0.0013 inches.

9. A method of treating a lesion comprising:

providing an occlusion device consisting essentially of

a carrier member, and

an elongated, solid expansile element, that is flexible in an untreated state, consisting essentially of a poly(ethylene glycol) macromer and a pH sensitive monomer to the lesion

wherein the elongated, solid expansile element is secured to the carrier member in a stretched configuration that is between about 125% and about 600% of its initial length and the carrier member is formed into a secondary configuration that is approximately the same diameter as the lesion.

10. The method of claim 9 , wherein the poly(ethlyene glycol) macromer has a molecular weight of about 400 grams/mole to about 35,000 grams/mole.

11. The method of claim 9 , wherein the carrier element is between about 0.005 inches and about 0.035 inches in diameter.

12. The method of claim 9 , wherein the pH sensitive monomer is sodium acrylate.

13. The method of claim 9 , wherein the carrier element comprises a plurality of loops forming a helical shape disposed around the expansile element.

14. The method of claim 13 , wherein the plurality of loops are spaced by gaps.

15. The method of claim 14 , wherein at least one gap is configured to allow the elongated, solid, expansile element to expand through the at least one gap.

16. The method of claim 15 , wherein the at least one gap has a distance of about 0.00025 inches to about 0.2 inches.

17. The method of claim 16 , wherein the at least one gap has a distance of about 0.00025 inches to about 0.005 inches.

18. The method of claim 15 , wherein the at least one gap has a distance of about 0.0013 inches.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2016
From: CRUISE, GREGORY M.; CONSTANT, MICHAEL; TRAN, TERRANCE
To: MICROVENTION, INC.
Reel/Frame 039468/0221 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2016
From: GULACHENSKI, JOSEPH
To: MICROVENTION, INC.
Reel/Frame 039468/0316 →
Continuity (4)
Continuation 13553275 · Jul 19, 2012
Continuation 11764111 · Jun 15, 2007
Provisional Application 60814309 · Jun 15, 2006
Related Publication 20160345978A1 · Dec 1, 2016